1011 — China NT Pharma Co Share News
0.000.00%
Last trade - 00:00- HK$436.54m
- HK$794.62m
- CNY24.16m
Brief: China NT Pharma Group Announces Termination Of Deal Relaed To Hong Kong WD Pharmaceutical
Brief: Shanghai Jiaoda Onlly, Unit To Unload Up To Entire 18.8% Stake In China NT Pharma
Brief: China NT Pharma Says Golden Base Transferred 200 Million Shares Of Co On 6 Nov
Brief: China NT Pharma Group To Buy 40% Stake In Hong Kong WD Pharmaceutical
Brief: China NT Pharma Group Says Trading In Its Shares On Stock Exchange Of Hong Kong Has Been Halted
Brief: China NT Pharma Group Company Expects Profit For Six Months Ending 30 June 2019
Brief: China NT Pharma Group Shares On Trading Halt
Brief: China NT Pharma To Place Convertible Bonds In Principal Amount Of Up To HK$192.8 Mln
Brief: China NT Pharma Group Co Posts FY Loss Attributable Rmb957.7 Mln
Brief: China NT Pharma Group Announces Termination Of Letter Of Intent In Relation To Possible Disposal
Brief: China NT Pharma Group Sees Consol Loss For FY
Brief: China NT Pharma Group Co Announces Placing Of Up To Hk$100 MLN Bonds
Brief: China NT Pharma Group's Board Approved & Adopted Dividend Policy On Jan 24
Brief: China Nt Pharma Group Appoints Wang Fei As An Executive Director
Brief: China NT Pharma Group Says Unit To Dispose Certain Equity Interests In Suzhou First Pharmaceutical
Brief: China NT Pharma Group Says Bank Approves Loan Of Up To US$40 Mln To Unit
Brief: China NT Pharma Group Co Posts HY Profit Attributable RMB82.9 Mln
Brief: Pfenex And NT Pharma Enter Into A Development And License Agreement For Pfenex's PF708 Therapeutic Equivalent Candidate To Forteo
Brief: China NT Pharma Group Co Appoints Wang Fei As CFO